Cellectar Biosciences (CLRB) Current Ratio: History & Chart

Cellectar Biosciences, Inc.(CLRB)

Biotechnology · Florham Park, NJ

$1.66-0.01 (-0.60%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

About Cellectar Biosciences, Inc.

Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies. Additionally, CLR 131 is being studied in Phase 2B for r/r multiple myeloma (MM) and in Phase I trials targeting a range of pediatric cancers, r/r head and neck cancers, and R/R MM. Furthermore, Cellectar is advancing CLR 1900, another PDC-based chemotherapeutic program, which is in preclinical stages with the aim of treating solid tumors. The firm also participates in collaborative PDC development initiatives with partners such as Avicenna Oncology GMBH for the CLR 2000 Series, Orano Med for the CLR 12120 Series, as well as IntoCell Inc. and LegoChemBio. Established in 2002, Cellectar Biosciences maintains its corporate headquarters in Florham Park, New Jersey.

Florham Park, NJ

11 employees

www.cellectar.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: James V. Caruso

View full financials

CLRB Current Ratio Metrics

CURRENT RATIO

6.66

CURRENT RATIO AVG TTM

3.29

CURRENT RATIO AVG 3Y

1.87

CURRENT RATIO AVG 5Y

2.61

CURRENT RATIO AVG 10Y

4.75

CURRENT RATIO AVG 15Y

4.42

CURRENT RATIO AVG 20Y

4.04

CURRENT VS TTM AVG

+102.53%

CURRENT VS 3Y AVG

+256.78%

CURRENT VS 5Y AVG

+155.18%

CURRENT VS 10Y AVG

+40.17%

CURRENT VS 15Y AVG

+50.82%

CURRENT VS 20Y AVG

+64.94%

SECTOR MEDIAN · HEALTHCARE

3.35

median of 509 covered companies

CURRENT VS SECTOR MEDIAN

+98.77%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
Cellectar Biosciences, Inc. (CLRB)	$13.26M	6.66	3.29	1.87	2.61
Vyome Holdings, Inc. (HIND)vs ›	$13.55M	4.37	1.46	1.74	1.95
IN8bio, Inc. (INAB)vs ›	$13.62M	8.21	6.45	5.32	7.60
Dare Bioscience, Inc. (DARE)vs ›	$12.63M	0.99	0.99	1.05	1.43
Cytosorbents Corporation (CTSO)vs ›	$12.46M	0.66	2.17	2.40	3.73
Citius Pharmaceuticals, Inc. (CTXR)vs ›	$14.28M	0.84	0.51	4.20	6.42
CytoMed Therapeutics Limited (GDTC)vs ›	$11.95M	2.64	7.53	7.44	5.23
IRIDEX Corporation (IRIX)vs ›	$11.94M	1.82	1.91	1.82	2.33
Karyopharm Therapeutics Inc. (KPTI)vs ›	$15.20M	0.79	1.41	2.88	3.31
Pasithea Therapeutics Corp. (KTTA)vs ›	$15.20M	26.25	8.96	10.61	33.19

NAME

MARKET CAP

CURRENT RATIO

TTM

Cellectar Biosciences, Inc. (CLRB)

$13.26M

6.66

3.29

1.87

2.61

Vyome Holdings, Inc. (HIND)vs ›

$13.55M

4.37

1.46

1.74

1.95

IN8bio, Inc. (INAB)vs ›

$13.62M

8.21

6.45

5.32

7.60

Dare Bioscience, Inc. (DARE)vs ›

$12.63M

0.99

1.05

1.43

Cytosorbents Corporation (CTSO)vs ›

$12.46M

0.66

2.17

2.40

3.73

Citius Pharmaceuticals, Inc. (CTXR)vs ›

$14.28M

0.84

0.51

4.20

6.42

CytoMed Therapeutics Limited (GDTC)vs ›

$11.95M

2.64

7.53

7.44

5.23

IRIDEX Corporation (IRIX)vs ›

$11.94M

1.82

1.91

1.82

2.33

Karyopharm Therapeutics Inc. (KPTI)vs ›

$15.20M

0.79

1.41

2.88

3.31

Pasithea Therapeutics Corp. (KTTA)vs ›

$15.20M

26.25

8.96

10.61

33.19

Current Ratio FAQ

What is the current ratio for Cellectar Biosciences, Inc. (CLRB)?

The current ratio for CLRB stock is 6.66.

Is Cellectar Biosciences, Inc.'s current ratio high or low?

The current ratio of 6.66 is 155% above its 5-year average of 2.61, around the middle of its 5-year range (0.41–13.39).

What is the TTM average current ratio for Cellectar Biosciences, Inc. (CLRB)?

The TTM average current ratio for CLRB stock is 3.29.

What is the 3Y average current ratio for Cellectar Biosciences, Inc. (CLRB)?

The 3Y average current ratio for CLRB stock is 1.87.

What is the 5Y average current ratio for Cellectar Biosciences, Inc. (CLRB)?

The 5Y average current ratio for CLRB stock is 2.61.

What is the 10Y average current ratio for Cellectar Biosciences, Inc. (CLRB)?

The 10Y average current ratio for CLRB stock is 4.75.

What is the 15Y average current ratio for Cellectar Biosciences, Inc. (CLRB)?

The 15Y average current ratio for CLRB stock is 4.42.

What is the 20Y average current ratio for Cellectar Biosciences, Inc. (CLRB)?

The 20Y average current ratio for CLRB stock is 4.04.

DATE	CURRENT RATIO
2026-06-30	6.66
2026-03-31	1.90
2025-12-31	2.96
2025-09-30	2.77
2025-06-30	2.15
2025-03-31	2.47
2024-12-31	2.58
2024-09-30	1.77
2024-06-30	1.84
2024-03-31	1.45
2023-12-31	0.41
2023-09-30	1.22
2023-06-30	0.87
2023-03-31	1.99
2022-12-31	1.78
2022-09-30	2.88
2022-06-30	4.51
2022-03-31	6.75
2021-12-31	9.16
2021-09-30	13.07
2021-06-30	13.39
2021-03-31	10.84
2020-12-31	16.26
2020-09-30	5.01
2020-06-30	6.94
2020-03-31	2.58
2019-12-31	4.11
2019-09-30	4.95
2019-06-30	6.80
2019-03-31	5.04
2018-12-31	8.60
2018-09-30	6.43
2018-06-30	2.19
2018-03-31	3.63
2017-12-31	4.95
2017-09-30	3.14
2017-06-30	5.88
2017-03-31	8.71
2016-12-31	7.47
2016-09-30	4.31
2016-06-30	5.84
2016-03-31	0.80
2015-12-31	0.73
2015-09-30	0.54
2015-06-30	0.86
2015-03-31	1.23
2014-12-31	1.56
2014-09-30	5.77
2014-06-30	0.49
2014-03-31	0.92
2013-12-31	0.61
2013-09-30	1.19
2013-06-30	0.99
2013-03-31	1.23
2012-12-31	7.00
2012-09-30	8.13
2012-06-30	11.55
2012-03-31	7.95
2011-12-31	11.55
2011-09-30	4.04
2011-06-30	7.74
2011-03-31	2.44
2010-12-31	2.69
2010-09-30	0.54
2010-06-30	0.64
2010-03-31	0.98
2009-12-31	0.52
2009-09-30	0.80
2009-06-30	0.58
2009-03-31	1.43
2008-12-31	0.21
2008-09-30	0.63
2008-06-30	0.69
2008-03-31	0.69
2007-12-31	1.57
2007-09-30	3.29
2007-06-30	7.03
2007-03-31	7.34
2006-12-31	9.05
2006-09-30	12.90
2006-06-30	26.07
2006-03-31	37.47
2005-12-31	22.11
2005-09-30	8.13
2005-06-30	2.35
2005-03-31	0.00

DATE

CURRENT RATIO

2026-06-30

6.66

2026-03-31

1.90

2025-12-31

2.96

2025-09-30

2.77

2025-06-30

2.15

2025-03-31

2.47

2024-12-31

2.58

2024-09-30

1.77

2024-06-30

1.84

2024-03-31

1.45

2023-12-31

0.41

2023-09-30

1.22

2023-06-30

0.87

2023-03-31

1.99

2022-12-31

1.78

2022-09-30

2.88

2022-06-30

4.51

2022-03-31

6.75

2021-12-31

9.16

2021-09-30

13.07

2021-06-30

13.39

2021-03-31

10.84

2020-12-31

16.26

2020-09-30

5.01

2020-06-30

6.94

2020-03-31

2.58

2019-12-31

4.11

2019-09-30

4.95

2019-06-30

6.80

2019-03-31

5.04

2018-12-31

8.60

2018-09-30

6.43

2018-06-30

2.19

2018-03-31

3.63

2017-12-31

4.95

2017-09-30

3.14

2017-06-30

5.88

2017-03-31

8.71

2016-12-31

7.47

2016-09-30

4.31

2016-06-30

5.84

2016-03-31

0.80

2015-12-31

0.73

2015-09-30

0.54

2015-06-30

0.86

2015-03-31

1.23

2014-12-31

1.56

2014-09-30

5.77

2014-06-30

0.49

2014-03-31

0.92

2013-12-31

0.61

2013-09-30

1.19

2013-06-30

0.99

2013-03-31

1.23

2012-12-31

7.00

2012-09-30

8.13

2012-06-30

11.55

2012-03-31

7.95

2011-12-31

11.55

2011-09-30

4.04

2011-06-30

7.74

2011-03-31

2.44

2010-12-31

2.69

2010-09-30

0.54

2010-06-30

0.64

2010-03-31

0.98

2009-12-31

0.52

2009-09-30

0.80

2009-06-30

0.58

2009-03-31

1.43

2008-12-31

0.21

2008-09-30

0.63

2008-06-30

0.69

2008-03-31

0.69

2007-12-31

1.57

2007-09-30

3.29

2007-06-30

7.03

2007-03-31

7.34

2006-12-31

9.05

2006-09-30

12.90

2006-06-30

26.07

2006-03-31

37.47

2005-12-31

22.11

2005-09-30

8.13

2005-06-30

2.35

2005-03-31

0.00

Current Ratio: 6.66

CLRB Current Ratio

CLRB Average Current Ratio Chart

CLRB Current vs Average Current Ratio Chart

CLRB Current Ratio Metrics

CLRB Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

CLRB Current Ratio History

Related Metrics